Clinical Trial Update: Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic Uncoupling [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pilot trial studying metformin in head and neck squamous cell carcinoma and its effects on stromal-epithelial metabolic uncoupling has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Head and Neck Squamous Cell Cancer | EARLY_Phase 1 | Status: COMPLETED